Literature DB >> 10527592

Current treatment for colorectal cancer metastatic to the liver.

M Cromheecke1, K P de Jong, H J Hoekstra.   

Abstract

Surgery is currently the only available treatment option which offers the potential for cure for patients with liver metastases from colorectal cancer. Of those who undergo a potentially curative operation for their primary tumour but subsequently recur, almost 80% will develop evidence of metastatic disease within the liver. Greater experience and improvements in technique in liver surgery, with an increasingly aggressive surgical approach to metastatic colorectal cancer to the liver, has resulted in prolonged disease-free survival with 5-year rates varying from 21% to 48%. In order to increase these numbers further and to treat patients not eligible for surgical therapy, new treatment modalities and strategies have been developed. This review presents an update of the current treatment for colorectal disease metastatic to the liver.

Entities:  

Mesh:

Year:  1999        PMID: 10527592     DOI: 10.1053/ejso.1999.0679

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  20 in total

1.  The role of RCAS1 as a biomarker in diagnosing CRC and monitoring tumor recurrence and metastasis.

Authors:  Su-xia Han; Jing Wang; Li-juan Wang; Gui-hua Jin; Xia Ying; Chen-chen He; Xi-jing Guo; Jian-ying Zhang; Ying Zhang; Qing Zhu
Journal:  Tumour Biol       Date:  2014-03-21

2.  Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients.

Authors:  Masaya Sato; Ryosuke Tateishi; Hideo Yasunaga; Hiromasa Horiguchi; Haruhiko Yoshida; Shinya Matsuda; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2012-03-17       Impact factor: 7.527

3.  Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52.

Authors:  John S Bolton; Michael J O'Connell; Michelle R Mahoney; Gist H Farr; Tom R Fitch; William J Maples; David M Nagorney; Joseph Rubin; Jyotsna Fuloria; Preston D Steen; Steven R Alberts
Journal:  Clin Colorectal Cancer       Date:  2011-05-13       Impact factor: 4.481

4.  Cyclooxygenase-2 expression in colorectal cancer liver metastases.

Authors:  M A Hull; S W Fenwick; K S Chapple; N Scott; G J Toogood; J P Lodge
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

5.  Changes in growth factor levels after thermal ablation in a murine model of colorectal liver metastases.

Authors:  Theodora Fifis; Caterina Malcontenti-Wilson; Jason Amijoyo; Beatrice Anggono; Vijayaragavan Muralidharan; Mehrdad Nikfarjam; Christopher Christophi
Journal:  HPB (Oxford)       Date:  2011-03-02       Impact factor: 3.647

6.  Liver resective surgery: a multivariate analysis of postoperative outcome and complication.

Authors:  Enrico Benzoni; Alessandro Cojutti; Dario Lorenzin; Gian Luigi Adani; Umberto Baccarani; Alessandro Favero; Aron Zompicchiati; Fabrizio Bresadola; Alessandro Uzzau
Journal:  Langenbecks Arch Surg       Date:  2006-09-16       Impact factor: 3.445

7.  Long-term survival of patients with unresectable colorectal liver metastases treated by percutaneous interstitial laser thermotherapy.

Authors:  Christopher Christophi; Mehrdad Nikfarjam; Caterina Malcontenti-Wilson; Vijayaragavan Muralidharan
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

Review 8.  Current treatment for liver metastases from colorectal cancer.

Authors:  Lian-Xin Liu; Wei-Hui Zhang; Hong-Chi Jiang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  Whole-liver radiotherapy for end-stage colorectal cancer patients with massive liver metastases and advanced hepatic dysfunction.

Authors:  Seung-Gu Yeo; Dae Yong Kim; Tae Hyun Kim; Sun Young Kim; Yong Sang Hong; Kyung Hae Jung
Journal:  Radiat Oncol       Date:  2010-10-26       Impact factor: 3.481

10.  Value of laparoscopy and laparoscopic ultrasonography in determining resectability of colorectal hepatic metastases.

Authors:  M Gholghesaei; J M van Muiswinkel; J W Kuiper; G Kazemier; H W Tilanus; J N M Ijzermans
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.